Ian Hampson

3.6k citations

58 papers · 2.8k indexed · 1 hit paper · h-index 25

Impact in

Cell Biology top 1%
- Proteoglycans and glycosaminoglycans research
Immunology and Allergy top 5%
- Cell Adhesion Molecules Research

Papers in

Cell Biology 14
- Proteoglycans and glycosaminoglycans research 10
Epidemiology 22
- Cervical Cancer and HPV Research 18
- Hepatitis B Virus Studies 7

Co-authors: David C. West Frank Arnold Sandeep Kumar Lynne Hampson Chenggang Li Shant Kumar Henry C Kitchener Carmelo Bernabéu
Journals: Viruses (4 papers)Biochemical Journal (3 papers)Antiviral Therapy (3 papers)PLoS ONE (3 papers)Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry (2 papers)
Partner nations: United Kingdom Canada Kenya

In The Last Decade

Ian Hampson

57 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

Angiogenesis Induced by Degradation Products of Hyaluronic Acid 1985 · 949 citations

Peers

Countries citing papers authored by Ian Hampson

Since Specialization

Citations

This map shows the geographic impact of Ian Hampson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Hampson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Hampson more than expected).

Fields of papers citing papers by Ian Hampson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Hampson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Hampson. The network helps show where Ian Hampson may publish in the future.

Co-authors

The 25 scholars most cited alongside Ian Hampson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ian Hampson Line = papers co-authored together Ian Hampson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Synergistic Autophagy-Related Mechanisms of Protection Against Brain Aging and AD: Cellular Pathways and Therapeutic Strategies Pharmaceuticals ·Agliardi Gian Luca, M. Dhanushkumar, Ian Hampson, Anthony W. Oliver, Mark Slevin	2025	2
2	Analysis of human total antibody repertoires in TIF1γ autoantibody positive dermatomyositis Communications Biology ·Spyridon Megremis, Érica Santos Francischinelli Pazzini, Xiaotong He, James D.B. O’Sullivan, William Ollier, Hector Chinoy, Neil Pendleton, Antony Payton, Lynne Hampson, Ian Hampson, Janine A. Lamb	2021	13
3	Modulatory effects of curcumin on apoptosis and cytotoxicity-related molecules in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients Biomedicine & Pharmacotherapy ·Asadollah Mohammadi, Bahare Fazeli, Marzieh Taheri, Amirhossein Sahebkar, Naeimeh Elkhani, Caroline Kepnes, Adriana da Silva Flores Fabrão Moraes, 浩二酒井, Reza Boostani, Ian Hampson, Houshang Rafatpanah	2016	31
4	Silver nanoparticles exhibit size-dependent differential toxicity and induce expression of syncytin-1 in FA-AML1 and MOLT-4 leukaemia cell lines Mutagenesis ·マヌエル・E. ブリト, K E Fenesy, Anthony W. Oliver, Xiaotong He, Érica Santos Francischinelli Pazzini, Andrew C. Povey, Lynne Hampson, Ian Hampson	2016	9
5	A Single-Arm, Proof-Of-Concept Trial of Lopimune (Lopinavir/Ritonavir) as a Treatment for HPV-Related Pre-Invasive Cervical Disease PLoS ONE ·Lynne Hampson, Michael Caswell, Shen Xiaolan, Anthony W. Oliver, Odile Teeten, Xiaotong He, H. M. Jeewantha De Silva, 陈炽文, Helen F. Stringfellow, Pierre L. Martin‐Hirsch, Valeria Zakurazhnaya, Peter Gichangi, Ian Hampson	2016	32
6	A metabolomics investigation into the effects of HIV protease inhibitors on HPV16 E6 expressing cervical carcinoma cells Molecular BioSystems ·Dong‐Hyun Kim, J. William Allwood, Sara Martínez Gómez, Zulma Inés Otálora Barreto, Warwick B. Dunn, Yun Xu, Lynne Hampson, Ian Hampson, Royston Goodacre	2014	7
7	Analysis of Factors Contributing to the Low Survival of Cervical Cancer Patients Undergoing Radiotherapy in Kenya PLoS ONE ·Michael Caswell, Lynne Hampson, Anthony W. Oliver, Mohamed Gamal El‐Din, Peter Gichangi, 光治小林, Martínez Parra D, Ian Hampson	2013	92
8	Therapy of Human Papillomavirus-Related Disease Vaccine ·Peter L. Stern, Sjoerd H. van der Burg, Ian Hampson, Thomas R. Broker, Alison Fiander, Charles Lacey, Henry C Kitchener, Mark H. Einstein	2012	120
9	PLEXIN D1: NEW POTENTIAL BIOMARKER FOR CERVICAL CANCER Journal of Immunoassay and Immunochemistry ·Manal Shalaby, Lynne Hampson, Anthony W. Oliver, Ian Hampson	2012	8
10	No Biological Evidence of XMRV Infection in Cervical Smears from HIV/ HPV Positive and Negative Kenyan Women PLoS ONE ·Xiaotong He, Érica Santos Francischinelli Pazzini, Michael Caswell, Anthony W. Oliver, Lynne Hampson, Ian Hampson	2012	3
11	Lopinavir shows greater specificity than zinc finger ejecting compounds as a potential treatment for human papillomavirus-related lesions Antiviral Research ·Ingeborg Zehbe, Christina Richard, Giovanna Lombardo, Michael J. Campbell, Lynne Hampson, Ian Hampson	2011	8
12	Lopinavir Up-Regulates Expression of the Antiviral Protein Ribonuclease L in Human Papillomavirus-Positive Cervical Carcinoma Cells Antiviral Therapy ·Odile Teeten, Anthony W. Oliver, Ingeborg Zehbe, Christina Richard, Lynne Hampson, Ian Hampson	2010	25
13	Cidofovir induces an increase in levels of low‐risk and high‐risk HPV E6 Head & Neck ·Adam J. Donne, Lynne Hampson, Xiaotong He, Michael Rothera, Jarrod J. Homer, Ian Hampson	2009	14
14	Analogues of Y27632 increase gap junction communication and suppress the formation of transformed NIH3T3 colonies British Journal of Cancer ·Lynne Hampson, Xiaotong He, Antony W. Oliver, John A. Hadfield, Qiao Wen-jing, J. A. V. Butler, Andrew McGown, Henry C Kitchener, Ian Hampson	2009	10
15	Tumor Epression of Major Vault Protein is an Adverse Prognostic Factor for Radiotherapy Outcome in Oropharyngeal Carcinoma International Journal of Radiation OncologyBiologyPhysics ·Priyamal Silva, Catharine West, N.J. Slevin, Helen Valentine, W. David J. Ryder, Lynne Hampson, Mustafa Surti, Philip Sloan, Nalin Thakker, Jarrod J. Homer, Ian Hampson	2007	20
16	Upstream elements bestow T-cell and haemopoietic progenitor-specific activity on the granzyme B promoter Gene ·Y. Miyauchi, Anggita Listiana, Reinhard Henschler, Ian Hampson, Clare M. Heyworth, Kuntal Goswami, R. Chris Bleackley, T. M. Dexter, Michael Cross	1999	4
17	Induced reversion of a spontaneous point mutation within the Chinese hamster HPRT gene to the wild-type sequence Mutagenesis ·Belinda J. F. Rossiter, Donna M. Muzny, Ian Hampson, C. Thomas Caskey, Margaret Fox	1990	4
18	Identification of an extended N-acetylated sequence adjacent to the protein-linkage region of fibroblast heparan sulphate Biochemical Journal ·Malcolm Lyon, William P. Steward, Ian Hampson, J T Gallagher	1987	39
19	Heterogeneity of cell-associated and secretory heparan sulphate proteoglycans produced by cultured human neuroblastoma cells Biochimica et Biophysica Acta (BBA) - General Subjects ·Ian Hampson, Suresh Kumar, J.A. Gallagher	1984	19
20	Differences in the distribution of O-sulphate groups of cell-surface and secreted heparan sulphate produced by human neuroblastoma cells in culture Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Ian Hampson, Shant Kumar, John T. Gallagher	1983	14

About Ian Hampson

Ian Hampson is a scholar working on Cell Biology, Epidemiology, Immunology, Oncology and Virology, having authored 58 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (18 papers), Proteoglycans and glycosaminoglycans research (10 papers), Glycosylation and Glycoproteins Research (7 papers), Hepatitis B Virus Studies (7 papers), Virus-based gene therapy research (6 papers), T-cell and Retrovirus Studies (6 papers), Molecular Biology Techniques and Applications (5 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Cell Biology (948 citations), Immunology and Allergy (179 citations), Cancer Research (309 citations), Epidemiology (656 citations) and Molecular Biology (1.2k citations). Ian Hampson has collaborated with scholars based in United Kingdom, Canada and Kenya. Frequent co-authors include David C. West, Frank Arnold, Sandeep Kumar, Lynne Hampson, Chenggang Li, Shant Kumar, Henry C Kitchener, Carmelo Bernabéu, Pat Kumar and Anthony W. Oliver. Their work appears in journals such as Viruses, Biochemical Journal, Antiviral Therapy, PLoS ONE and Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact